CRIS Current Research Information System

FRANCHINI, EUGENIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.005
AS - Asia 1.872
EU - Europa 1.696
AF - Africa 182
SA - Sud America 91
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.856
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.971
VN - Vietnam 554
CN - Cina 502
SG - Singapore 483
GB - Regno Unito 416
IT - Italia 310
SE - Svezia 244
DE - Germania 203
HK - Hong Kong 116
NL - Olanda 93
FR - Francia 82
IN - India 79
RU - Federazione Russa 77
BR - Brasile 65
IE - Irlanda 61
TG - Togo 53
FI - Finlandia 42
NG - Nigeria 40
KR - Corea 39
CI - Costa d'Avorio 35
ZA - Sudafrica 31
EE - Estonia 29
BG - Bulgaria 27
CA - Canada 27
BE - Belgio 24
JO - Giordania 23
UA - Ucraina 19
SC - Seychelles 17
AT - Austria 15
CH - Svizzera 14
ID - Indonesia 14
JP - Giappone 14
AR - Argentina 13
PL - Polonia 11
UZ - Uzbekistan 8
GR - Grecia 7
BD - Bangladesh 6
IR - Iran 6
MX - Messico 6
TR - Turchia 6
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
ES - Italia 4
EU - Europa 4
KE - Kenya 4
IQ - Iraq 3
LT - Lituania 3
MK - Macedonia 3
PE - Perù 3
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PT - Portogallo 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
DK - Danimarca 1
EC - Ecuador 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 5.856
Salva come PNG Salva come JPEG
Città #
Dong Ket 425
Southend 381
Singapore 312
Ashburn 269
Chandler 219
Fairfield 150
Ann Arbor 134
Hong Kong 115
Beijing 92
Hefei 87
Seattle 87
Houston 78
Bologna 75
Wilmington 74
Woodbridge 70
Cambridge 67
Boardman 64
Dublin 61
Princeton 58
Lomé 53
New York 43
Santa Clara 40
Seoul 39
Milan 37
Abidjan 35
Munich 32
Abeokuta 29
Westminster 29
Padova 28
Ho Chi Minh City 27
Nanjing 27
Sofia 27
Los Angeles 26
Medford 25
Helsinki 24
Amman 23
Brussels 23
Hanoi 22
Bremen 18
Redondo Beach 18
Berlin 16
Jinan 16
Dallas 14
Redwood City 14
Buffalo 13
Changsha 12
Frankfurt am Main 12
Hebei 12
Saint Petersburg 12
Tokyo 12
Toronto 12
Turku 12
Vienna 12
Bern 11
Guangzhou 11
Nanchang 11
Shenyang 11
Jakarta 10
Paris 10
Rome 10
Shanghai 9
Bengaluru 8
Jiaxing 8
São Paulo 8
Turin 8
Amsterdam 7
Florence 7
Hangzhou 7
Hyderabad 7
Monzuno 7
Moscow 7
Redmond 7
Warsaw 7
Chengdu 6
Falls Church 6
Lappeenranta 6
Nuremberg 6
Romainville 6
San Diego 6
Zhengzhou 6
Brooklyn 5
London 5
Mountain View 5
Taizhou 5
Athens 4
Belo Horizonte 4
Denver 4
Falkenstein 4
Hải Dương 4
Leawood 4
Manchester 4
Modigliana 4
Monmouth Junction 4
Montreal 4
Ottawa 4
Stockholm 4
Thái Nguyên 4
Tianjin 4
Tongling 4
Washington 4
Totale 3.909
Salva come PNG Salva come JPEG
Nome #
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 332
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 258
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival 240
Alterations in phosphatidylinositol 3-phosphate (PI3P) pathway and cAMP pathway confirm poor prognosis and reduced overall survival (OS) in a series of 209 acute myeloid leukemia patients 230
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 218
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up 214
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 211
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 209
Chromothripsis in Acute Myeloid Leukemia Is Strongly Associated with Poor Prognosis and TP53 Alterations 206
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 200
H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma 169
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 167
Deficient necroptosis pathway as a negative prognostic factor in acute myeloid leukemia. 167
Copy number variants signature in two patients with relapsed acute promyelocytic leukemia 166
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 163
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study 159
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 153
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 153
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 152
Survival and outcome data observed in 98 patients affected by acute myeloid leukemia undergoing chemotherapy consolidation courses treatment followed by autologous bone marrow transplantation (auto-BMT) 150
Microarray analysis to identifiy novel copy number alterations in acute myeloid leukemia 150
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 149
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients 139
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 134
"Paradoxical" p16 overexpression in cutaneous melanoma: Molecular and immunohistochemical analysis of a rare phenomenon with a focus on cell cycle regulatory molecules 130
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 127
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 127
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis 125
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 125
Evaluation of the Diasorin Q-Lamp technology for the molecular diagnosis of the philadelphia positive leukemias: an italian multicenter study 122
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 121
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type 119
Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients 113
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 103
Characterization of testicular embryonic-type neuroectodermal tumor and embryonic-type neuroectodermal tissue admixed with mature neuro-glial tissue using a broad immunohistochemical panel 90
SOX2 and PRAME in the "reprogramming" of seminoma cells 77
Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1…but choriocarcinoma? 54
Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumors 36
Immunohistochemical expression of Nectin-4 and potential implications for enfortumab vedotin therapy in germ cell tumors of the testis: a preliminary study 23
Totale 5.981
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021741 0 0 0 0 0 30 24 45 54 22 39 527
2021/2022660 34 26 38 70 64 35 20 29 31 48 144 121
2022/2023914 108 134 54 121 77 69 32 41 144 29 62 43
2023/2024342 18 38 25 60 19 82 14 26 18 14 8 20
2024/20251.002 26 141 96 77 74 27 107 41 21 110 74 208
2025/20261.097 239 173 188 183 265 49 0 0 0 0 0 0
Totale 5.981